CORNOVA
CorNova® is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in better patient outcomes without added procedure time and patient risk. The FiberHalo™ stent deployment catheter will enable the physician to deploy a stent and measure in-stent lumen area during the procedure. The FiberHalo™ post-dilatation catheter will enable the physician to correct for any under-expansion and also measure p... ost-dilatation results. CorNova is also developing a pre-dilatation version of the FiberHalo™, which will enable the physician to determine likelihood of mechanical failure of stent deployment, allowing for better decision making. CorNova has recently received CE certification on the Valecor Platinum™ stent (a bare metal stent with a pure platinum surface for increased biocompatibility and designed to reduce arterial injury), which has shown superior performance and anti-restenosis properties compared to current bare metal stents.
CORNOVA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-10-01
Address:
Burlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.cornova.com
Total Employee:
11+
Status:
Active
Contact:
781-270-0055
Email Addresses:
[email protected]
Total Funding:
10.89 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Apache Mobile Non Scaleable Content Nginx Amazon Route 53 DigiCert SSL CloudFront
Similar Organizations
Ground Zero Pharmaceuticals
Ground Zero Pharmaceuticals provides integrated consultation in medical products and services.
Opulus
Opulus developes and integrates technology for pharmaceutical industry.
Current Employees Featured
Investors List
Implant Sciences
Implant Sciences investment in Series A - CorNova
CardioTech
CardioTech investment in Series A - CorNova
